Drug Trial Radar · NCT05668403
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
Last checked: Nov 19, 2026Latest source record: Apr 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
52
Planned (sponsor's estimate)
Start
Mar 2, 2023
Primary completion
Dec 30, 2026
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- Shanghai Jiaolian Drug Research and Development Co., LtdIndustry
- Sponsor type
- Industry
- Collaborators
- Shanghai Pharmaceuticals Holding Co., Ltd
- First posted
- Dec 29, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase I Clinical Study assessed the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles and Preliminary Efficacy of Subcutaneous Injection of Recombinant Humanized Anti-CD20 Monoclonal Antibody in the Treatment of Primary Membranous Nephropathy
Conditions
- Primary Membranous Nephropathy
Interventions
B007Drug
Drug: B007 injection Drug: Placebo injection
B007Drug
Drug: B007 injection Drug: Placebo injection
B007Drug
Drug: B007 injection Drug: Placebo injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dose limiting toxicity(DLT)Time frame: Approximately 1 years
- Security: Incidence of Treatment-Emergent Adverse EventsTime frame: Approximately 2 years
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Peking university first hospital
Beijing, China · Recruiting
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Shanghai, China · Recruiting
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Shanghai, China · Recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, He'nan, China · Recruiting
Hebei General Hospital
Shijiazhuang, Hebei, China · Recruiting
The First Affiliated Hospital,College of Medicine,Zhejiang University
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.